This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Scinopharm Taiwan, Ltd.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Hsin-Chang Tseng: Innovator in Pharmaceutical Processes
Introduction
Hsin-Chang Tseng is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of elagolix sodium and its intermediates. His innovative approach has the potential to enhance production processes in the pharmaceutical industry.
Latest Patents
Hsin-Chang Tseng holds a patent for a process titled "Process for preparing elagolix sodium and intermediates thereof." This invention provides improved methods for synthesizing elagolix and its intermediates. The process is designed for large-scale production, effectively avoiding the use of potential genotoxic substances and can be performed under mild conditions. He has 1 patent to his name.
Career Highlights
Tseng is currently employed at Scinopharm Taiwan, Ltd., where he continues to develop innovative pharmaceutical processes. His work is instrumental in advancing the efficiency and safety of drug production.
Collaborations
He collaborates with talented coworkers, including Yung-Hung Chang and Tsung-Yu Hsiao, who contribute to the innovative environment at Scinopharm Taiwan, Ltd.
Conclusion
Hsin-Chang Tseng's contributions to pharmaceutical processes exemplify the impact of innovation in the industry. His work not only enhances production methods but also prioritizes safety and efficiency.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile